Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients
出版年份 2017 全文链接
标题
Detection of HER2 Amplification in Circulating Tumor Cells of HER2-Negative Gastric Cancer Patients
作者
关键词
Gastric Cancer, Trastuzumab, Overall Response Rate, EpCAM Expression, CellSearch System
出版物
Targeted Oncology
Volume 12, Issue 3, Pages 341-351
出版商
Springer Nature
发表日期
2017-05-16
DOI
10.1007/s11523-017-0493-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients
- (2016) Shaohua Zhang et al. BMC CANCER
- Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial
- (2016) Jifang Gong et al. BMC CANCER
- Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
- (2016) Bahriye Aktas et al. BMC CANCER
- A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer
- (2016) Hiromi Kataoka et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Extra-gain of HER2-positive cases through HER2 reassessment in primary and metastatic sites in advanced gastric cancer with initially HER2-negative primary tumours: Results of GASTric cancer HER2 reassessment study 1 (GASTHER1)
- (2016) Sook Ryun Park et al. EUROPEAN JOURNAL OF CANCER
- HER2 expression identifies dynamic functional states within circulating breast cancer cells
- (2016) Nicole Vincent Jordan et al. NATURE
- HER2 Status in Gastric Cancer: Comparison between Primary and Distant Metastatic Disease
- (2016) Michelina Amato et al. PATHOLOGY & ONCOLOGY RESEARCH
- A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation
- (2016) Henrik Frithiof et al. OncoTargets and Therapy
- MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
- (2016) Morten Lapin et al. Scientific Reports
- Prognostic Impact of HER2 and ER Status of Circulating Tumor Cells in Metastatic Breast Cancer Patients with a HER2-Negative Primary Tumor
- (2016) Nick Beije et al. NEOPLASIA
- Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer
- (2015) Phillip Stahl et al. BMC GASTROENTEROLOGY
- Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer
- (2015) Min-Hee Ryu et al. EUROPEAN JOURNAL OF CANCER
- High-resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
- (2015) Barry M. Dent et al. INTERNATIONAL JOURNAL OF CANCER
- Concordance of HER2 expression in paired primary and metastatic sites of gastric and gastro-oesophageal junction cancers
- (2015) Daniel D. Wong et al. PATHOLOGY
- The detection of EpCAM+ and EpCAM– circulating tumor cells
- (2015) Sanne de Wit et al. Scientific Reports
- EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer
- (2015) Helen Schneck et al. PLoS One
- Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)
- (2014) Y Kurokawa et al. BRITISH JOURNAL OF CANCER
- Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
- (2014) Costanza Paoletti et al. CLINICAL CANCER RESEARCH
- HER2 testing in gastric cancer: a practical approach
- (2012) Josef Rüschoff et al. MODERN PATHOLOGY
- Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients
- (2011) Robert Königsberg et al. ACTA ONCOLOGICA
- Intratumoral Heterogeneity Determines Discordant Results of Diagnostic Tests for Human Epidermal Growth Factor Receptor (HER) 2 in Gastric Cancer Specimens
- (2011) Jiyuan Yang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma
- (2011) Min A Kim et al. HISTOPATHOLOGY
- Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer
- (2011) Naoki Hayashi et al. International Journal of Clinical Oncology
- FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platform
- (2011) Julie Ann Mayer et al. Cancer Genetics
- HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
- (2010) Tanja Fehm et al. BREAST CANCER RESEARCH AND TREATMENT
- Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer
- (2010) L M Flores et al. BRITISH JOURNAL OF CANCER
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
- (2009) C. Simmons et al. ANNALS OF ONCOLOGY
- Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients
- (2009) Marta Pestrin et al. BREAST CANCER RESEARCH AND TREATMENT
- Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies
- (2008) Mitra Tewes et al. BREAST CANCER RESEARCH AND TREATMENT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started